← Leaderboards
Sang Van
Paramita Therapeutics, Inc.
$353,009
Attributed
$353,009
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$353,009 · 1
By mechanism
R43$353,009 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Anaphylaxis”
- Jacob Glanville · Centivax Inc$2,987,953
- Ricardo Valladares · Siolta Therapeutics, Inc.$2,921,132
- Abhichart Krissanaprasit · Helixomer, Inc.$2,042,027
- Weston Daniel · Evoq Therapeutics, Inc.$1,988,943
- Jonathan Lyons · University Of California, San Diego$1,565,919
- Catherine Mary Ptaschinski · University Of Michigan At Ann Arbor$1,183,923
Research focus
AnaphylaxisAndrogen Independent Prostate CancerAngioneurotic EdemaAntigen TargetingAntineoplastic AgentsAqueousAutopsyBindingBoneBreast Cancer Cell LineCancer Cell LineCancer DiagnosisCancer EtiologyCancer PatientCause Of DeathCell LineCell MembraneCellsCessation Of LifeChemotherapyCytotoxicityDiagnosisDistressAffinity